Biblio Discovery — Demo Discovery Service

15 results for "Intissar Anan"

Showing 1–15 · 0.43 seconds · RSS

  1. Journal Article

    Advances in the treatment of transthyretin amyloidosis

    Intissar Anan

    eGastroenterology, Vol. 3 No. 3 · 2025 · English · DOAJ Scopus

    This review aims to provide a comprehensive overview of the existing therapeutic options for managing neuropathic and/or cardiac manifestations associated with transthyretin amyloidosis (ATTR), along with investigational therapeutic candidates under evaluation in ongoing clinical trials…

  2. Journal Article

    Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis

    Sandra Arvidsson; Robert Eriksson; Intissar Anan et al.

    Annals of Medicine, Vol. 55 No. 2 · 2023 · English · DOAJ Scopus

    AbstractIntroduction In hereditary transthyretin amyloidosis (ATTRv), two different fibrillar forms causing the amyloid deposition, have been identified, displaying substantially cardiac or neuropathic symptoms. Neuropathic symptoms are more frequent in early-onset patients, whereas late-onset…

  3. Journal Article Full text

    Amyloid fibril composition within hereditary Val30Met ( p . Val50Met ) transthyretin amyloidosis families

    Ole Bernt Suhr; Jonas Wixner; Intissar Anan et al.

    PLOS ONE, Vol. 14 No. 2 · 2019 · English · PLOS Scopus

    Background: The amyloid fibril in hereditary transthyretin (TTR) Val30Met (pVal50Met) amyloid (ATTR Val30Met) amyloidosis is composed of either a mixture of full-length and TTR fragments (Type A) or of only full-length TTR (Type B). The type of amyloid fibril exerts an impact on the phenotype of…

    Also available at: DOAJ

  4. Journal Article Full text

    Amyloid fibril composition type is consistent over time in patients with Val30Met ( p . Val50Met ) transthyretin amyloidosis

    Intissar Anan; Ole B. Suhr; Katarzyna Liszewska et al.

    PLOS ONE, Vol. 17 No. 3 · 2022 · English · PLOS Scopus

    Background: We have previously shown that transthyretin (TTR) amyloidosis patients have amyloid fibrils of either of two compositions; type A fibrils consisting of large amounts of C-terminal TTR fragments in addition to full-length TTR, or type B fibrils consisting of only full-length TTR. Since…

    Also available at: DOAJ

  5. Journal Article Full text

    Endogenous Human Proteins Interfering with Amyloid Formation

    Anna L. Gharibyan; Sanduni Wasana Jayaweera; Manuela Lehmann et al.

    Biomolecules, Vol. 12 No. 3 · 2022 · English · DOAJ Scopus

    Amyloid formation is a pathological process associated with a wide range of degenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and diabetes mellitus type 2. During disease progression, abnormal accumulation and deposition of proteinaceous material are accompanied by tissue…

  6. Journal Article

    Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors

    Erica Irene Uneus; Christer Wilhelmsson; David Bäckström et al.

    Frontiers in Neurology, Vol. 13 · 2022 · English · DOAJ Scopus

    IntroductionHereditary transthyretin (ATTRv) amyloidosis caused by the V30M (p. V50M) mutation is a fatal, neuropathic systemic amyloidosis. Liver transplantation has prolonged the survival of patients and central nervous system (CNS) complications, attributed to amyloid angiopathy caused by CNS…

  7. Journal Article Full text

    Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study

    Erik Håkansson; Intissar Anan; Mattias Brunström et al.

    PLOS One, Vol. 21 No. 10 · 2026 · English · PLOS Scopus

    Background: The role of guideline-directed medical therapy for heart failure (HF) is unclear in transthyretin amyloid cardiomyopathy (ATTR-CM). Dapagliflozin has demonstrated beneficial effects across HF phenotypes, and retrospective studies suggest potential benefit in ATTR-CM; however…

  8. Journal Article

    Cardiac phenotype in hereditary transthyretin amyloidosis: correlations between fibril types and 99mTc-DPD uptake

    Viktor Löfbacka; Jonas Wixner; Per Westermark et al.

    Scientific Reports, Vol. 16 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Variant transthyretin amyloidosis is a systemic disease. In Sweden, the Val30Met variant is the most prevalent. Val30Met presents in two phenotypes: an early-onset form dominated by polyneuropathy and a late-onset form frequently accompanied by cardiomyopathy. These phenotypes are…

  9. Journal Article

    Structural basis for transthyretin amyloid formation in vitreous body of the eye

    Irina Iakovleva; Michael Hall; Melanie Oelker et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    Systemic ATTR amyloidosis causes the abnormal accumulation of ATTR fibrils formed from the human plasma protein transthyretin (TTR) in multiple organs including the eye. Here, the authors present a 3.2 Å cryo-EM structure of an ATTR fibril isolated from the vitreous body of an ATTR patient’s eye…

  10. Journal Article

    Evaluation of serum neurofilament light chain, GFAP, and peripherin as biomarkers in hereditary transthyretin amyloidosis

    Intissar Anan; Gabriella Johannson; Björn Pilebro et al.

    Scientific Reports, Vol. 16 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Early diagnosis and accurate monitoring of disease progression are crucial for timely therapeutic intervention in hereditary transthyretin amyloidosis (ATTRv). Neurofilament light chain (NfL) has emerged as a sensitive biomarker of neuroaxonal injury across neurodegenerative disorders…

  11. Journal Article

    Disrupted glutathione homeostasis in the pathogenesis of TTR-V30M amyloidosis

    Anushree Bachhar; Gabriella Johannson; Melisnur Sahin et al.

    Biomarker Research, Vol. 14 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Transthyretin (TTR) amyloidosis is a progressive, life-threatening disorder caused by extracellular deposition of amyloid fibrils derived from the plasma protein TTR. Inherited forms are associated with destabilizing TTR mutations; however, recent findings indicate that amyloid…

  12. Journal Article Full text

    Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation

    Sanduni Wasana Jayaweera; Solmaz Surano; Nina Pettersson et al.

    Biomolecules, Vol. 11 No. 3 · 2021 · English · DOAJ Scopus

    Amyloid-formation by the islet amyloid polypeptide (IAPP), produced by the β-cells in the human pancreas, has been associated with the development of type II diabetes mellitus (T2DM). The human plasma-protein transthyretin (TTR), a well-known amyloid-inhibiting protein, is interestingly also…

  13. Journal Article

    Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis

    Hedvig Paulsson Rokke; Nima Sadat Gousheh; Per Westermark et al.

    Orphanet Journal of Rare Diseases, Vol. 15 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background The diagnostic accuracy of histopathological detection of transthyretin amyloid (ATTR) by Congo red staining of abdominal fat samples has been questioned since low sensitivity has been reported, especially for patients with ATTR cardiomyopathy. However, the outcome of surgically…